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•Quantify the prescribing pattern changes of high-risk 
medications of the geriatric fellows before and after 
completing the program.
•Identify the geriatric fellows’ perceptions on 
deprescribing after completing the program.
Conclusions
High-Risk Medication Data:
•For most drug classes studied, deprescribing occurred 
more often than new starts. 
•Continuing high-risk medication use was very common 
across all drug classes.
Chart Review Data:
•The retrospective chart review identified cases of 
deprescribing that were not captured in the initial 
analysis. 
•Dose decrease occurred more often than dose 
increases.
Qualitative Survey Data:
•Geriatric fellowship respondents felt that they frequently 
attempted to deprescribe high-risk medications in older 
adults.
Limitations
•Randomized selection of continued high-risk medication 
cases only estimates the distribution of the population. 
•Limited number of primary care providers participating 
in the program. Data can easily be skewed by the 
practice of individual providers.
•The degree of life-limiting illness or patient life 
expectancy was not identified and would influence the 
potential for a medication to be inappropriate.6
•The cost impact of the Geriatric Mini-Fellowship 
program cannot be calculated from the results of this 
study.
•Literature suggests that deprescribing interventions 
implement in patients with limited life expectancy 
have potential for mortality reduction and cost 
savings.6
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Health & Services
•Geriatric patients are likely to experience adverse drug 
events related to high-risk medication use. Polypharmacy 
is also common and has a significant impact on the health 
of older adults.
•The American Geriatric Society Beers Criteria lists 
potentially inappropriate medications for older adults.1
•Current literature suggests that Implementing 
interventions and deprescribing practices have a role in 
reducing costly hospitalizations. 
•STOPP (Screening Tool of Older People’s Prescriptions) 
was designed to address polypharmacy.2
•Medication review and follow-up services for older, 
polypharmacy patients lowered medication-related 
costs.3
•Projections suggest there is an insufficient supply of 
geriatrician services.4
•Per person personal health care spending for people 65 
years and older is three times higher than spending per 
working-age adult.4 
• Individuals aged 65 and older are expected to increase 
from 14.5 percent of the U.S. population in 2014 to 
21.7 percent by 2040.5
• In 2018, a Geriatric Mini-Fellowship Program was 
implemented. The program was designed to:
• Increase primary care provider competencies in 
managing geriatric syndromes. 
•Train PCP’s to be geriatric medicine leaders to share 
awareness of geriatric care in their respective clinics.
•The program curriculum focused on the “Four M’s” of 
geriatric care.
•Medication, Mobility, Mentation, What Matters
•Two cohorts of fellows have graduated from the program.
Study Design
•Four high-risk medication drug classes were identified 
for an increased fall risk and were selected for this study.1
•Urinary Agents, Tricyclic Antidepressants, Muscle 
Relaxants, and Z-drugs
•Study Period
•May 2017 to May 2020
•Fellowship Cohort 1: Start Date April 16, 2018
•Pre-intervention: As of May 2018
•Post-intervention: As of May 2019
•Fellowship Cohort 2: Start Date April 20, 2019
•Pre-intervention: As of May 2019
•Post-intervention: As of May 2020
•Inclusion Criteria
•Adults aged 65 years and older
•Enrolled in the outpatient care of a geriatric fellow
•Participated in at least one PCP office visit in the pre-
intervention period and one visit in the post-
intervention period.
•Primary Endpoints
•Number of patients on a high-risk medication in the 
identified classes
•Number of high-risk medications in the Pre period
•Number of high-risk medications in the Post period
Qualitative Survey Results • Identify a method for obtaining a control group.•Compare prescribing pattern of primary care 
providers before and after participation in the 
Geriatric Mini-Fellowship.
•Describe the impact of the program on patient 
outcomes and cost.
• Investigate prescribing of other high-risk medication 
classes.
•Develop a plan to target high-risk medications that are 
considered most difficult to deprescribe.
Methods
Results
• Identify patients 
meeting inclusion 
criteria and on a 
high-risk medication 




review on random 
selection of patients 
who continued one 
HRM in the pre-




the geriatric fellows’ 
perceptions on 
prescribing patten via 
6-question Google 
Forms survey.
Percent of HRM Prescribed and 
Deprescribed in Both Cohorts (n=447) 
Deprescribing of Randomly Selected HRM 
Continued in Pre and Post Period (n=54)
Retrospective Chart Review
Total Dose Changes of Continued Medications
Eight of the twelve fellows (66.7%) 
responded to the survey.
2624 patients under the care of 9 primary care 
providers met inclusion criteria.
401 patients were on a high-risk medication at 
any point of the study period.
447 prescriptions written for HRM.
10049 prescriptions written for non-HRM.
54 of the 211 continued HRM were randomly 






















EASIEST HRM to Deprescribe
HARDEST HRM to Deprescribe
































Attempted to Deprescribe Dose Decreased

























After completing the Geriatric Mini-Fellowship, 
how often do you attempt to deprescribe high-
risk meds in older adults? 
(1=Never, 3=Sometimes, 5=Always)
Results (continued)
What barriers do you face when trying to deprescribe high-
risk medications in Geriatric patients? (Select all that apply)
151 medications deprescribed.
85 medications newly started in Post.
211 medications were continued.
Class Drug
Total Dose in 
Pre (mg)



























































0 2 4 6 8
Patient/Family is not agreeable
De-Rx attempted, but negative effects
De-Rx attempted, but could not follow
instructions
No time to deprescribe or follow up
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